1 |
Organization for Economic Cooperation and Development. OECD Health statistics 2018[Internet]. Paris: OECD; 2018[cited 2020 Jun 5]. Available from: https://stats.oecd.org/Index.aspx?DataSetCode=HEALTH_PHMC
|
2 |
Lee SY, Kim HS, Yoo J, Yoo JI, Jung YH. Sentinel surveillance and molecular epidemiology of multidrug resistance bacteria. Korean Journal of Clinical Microbiology. 2012;15(2):43-8. https://doi.org/10.5145/KJCM.2012.15.2.43
DOI
|
3 |
Centers for Disease Control and Prevention. Antibiotic resistance threats in the united states 2013[Internet]. Atlanta(GA): CDC; 2013[cited 2020 Jun 5]. Available from: https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf
|
4 |
Bassetti M, Nicolini L, Esposito S, Righi E, Viscoli C. Current status of newer carbapenems. Current Medicinal Chemistry. 2009;16(5):564-675. https://doi.org/10.2174/092986709787458498
DOI
|
5 |
Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria. The New England Journal of Medicine. 2010;362(19):1804-13. https://doi.org/10.1056/NEJMra0904124
DOI
|
6 |
Kang CI. Antimicrobial therapy for infections caused by multidrug-resistant gram-negative bacteria. The Korean Journal of Medicine. 2015;88(5):502-8. https://doi.org/10.3904/kjm.2015.88.5.502
DOI
|
7 |
Korea Centers for Disease Control and Prevention. 2017 Guidelines for health care associated infection(VRSA/CRE) prevention and control. Cheongju: KCDC; 2017.
|
8 |
Naas T, Nordmann P. Analysis of a carbapenem-hydrolyzing class a beta-lactamase from enterobacter cloacae and of its LysR-type regulatory protein. Proceedings of National Academy of Sciences of the United States of America. 1994;91(16):7693-7. https://doi.org/10.1073/pnas.91.16.7693
DOI
|
9 |
Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing enterobacteriaceae. Emerging Infectious Diseases. 2011;17(10):1791-1798. https://doi.org/10.3201/eid1710.110655
DOI
|
10 |
Go EB, Ju SJ, Park SD, Yoo JI, Hwang KJ. Distributions of carbapenem-resistant enterobacteriaceae (CRE) in Korea, 2018. PHWR. 2019;12(45):1977-83.
|
11 |
Nordmann P, Cuzon G, Naas T. The real threat of klebsiella pneumoniae carbapenemase-producing bacteria. The Lancet Infectious Diseases. 2009;9(4):228-36. https://doi.org/10.1016/S1473-3099(09)70054-4
DOI
|
12 |
Bleumin D, Cohen MJ, Moranne O, Esnault VL, Benenson S, Paltiel O, et al. Carbapenem-resistant klebsiella pneumoniae is associated with poor outcome in hemodialysis patients. Journal of Infection. 2012;65(4):318-25. https://doi.org/10.1016/j.jinf.2012.06.005
DOI
|
13 |
Jiao Y, Qin Y, Liu J, Li Q, Dong Y, Shang Y, et al. Risk factors for carbapenem-resistant klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study. Pathogens and Global Health. 2015;109(2):68-74. https://doi.org/10.1179/2047773215Y.0000000004
DOI
|
14 |
Dautzenberg MJ, Wekesa AN, Gniadkowski M, Antoniadou A, Giamarellou H, Petrikkos G L, et al. The association between colonization with carbapenemaseproducing enterobacteriaceae and overall ICU mortality: an observational cohort study. Critical Care Medicine. 2015;43(6):1170-7. https://doi.org/10.1097/CCM.0000000000001028
DOI
|
15 |
Shilo S, Assous MV, Lachish T, Kopuit P, Bdolah-Abram T, Yinnon AM, et al. Risk factors for bacteriuria with carbapenem-resistant klebsiella pneumoniae and its impact on mortality: a case-control study. Infection. 2013;41(2):503-9. https://doi.org/10.1007/s15010-012-0380-0
DOI
|
16 |
Ling ML, Tee YM, Tan SG, Amin IM, How KB, Tan KY, et al. Risk factors for acquisition of carbapenem resistant enterobacteriaceae in an acute tertiary care hospital in singapore. Antimicrobial Resist Infection Control. 2015;4(1):26. https://doi.org/10.1186/s13756-015-0066-3
DOI
|
17 |
Statistics Korea. The korean standard classification of diseases and causes of death, 2020[Internet]. Daejeon: Statistics Korea; 2020[cited 2020 sept 5]. Available from: https://kssc.kostat.go.kr:8443/ksscNew_web/index.jsp
|
18 |
Katsiari M, Panagiota G, Likousi S, Roussou Z, Polemis M, Alkiviadis VC, et al. Carbapenem-resistant klebsiella pneumoniae infections in a greek intensive care unit: molecular characterisation and treatment challenges. Jouranl of Global Antimicrob Resistance. 2015;3(2):123-127. https://doi.org/10.1016/j.jgar.2015.01.006
DOI
|
19 |
Correa L, Martino MD, Siqueira I, Pasternak J, Gales AC, Silva CV, et al. A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant klebsiella pneumoniae infection. BMC Infectious Diseases. 2013;13:80. https://doi.org/10.1186/1471-2334-13-80
DOI
|
20 |
Mariappan S, Sekar U, Kamalanathan A. Carbapenemase-producing enterobacteriaceae: risk factors for infection and impact of resistance on outcomes. International Journal of Applied Basic Medical Research. 2017;7(1):32-9. https://doi.org/10.4103/2229-516X.198520
DOI
|
21 |
Zhang S, Cui YL, Diao MY, Chen DC, Lin ZF. Use of platelet indices for determining Illness severity and predicting prognosis in critically ill patients. Chinese Medical Journal (Engl). 2015; 128(15):2012-8. https://doi.org/10.4103/0366-6999.161346
DOI
|
22 |
Ghoshal K, Bhattacharyya M. Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis. The Scientific World Journal. 2014;2014:1-16. https://doi.org/10.1155/2014/781857
DOI
|
23 |
Warny M, Helby J, Nordestgaard BG, Birgens H, Bojesen SE. Lymphopenia and risk of infection and infection-related death in 98,344 individuals from a prospective Danish population-based study. PLoS Medicine. 2018;15(11):e1002685. https://doi.org/10.1371/journal.pmed.1002685
DOI
|
24 |
Wakabayashi T. Mechanism of the calcium-regulation of muscle contraction-in pursuit of its structural basis. Proceedings of the Japan Academy, Series B. 2015;91(7):321-350. https://doi.org/10.2183/pjab.91.321
DOI
|
25 |
Ceccato A, Panagiotarakou M, Ranzani OT, Martin-Fernandez M, Almansa-Mora R, Gabarrus A, et al. Lymphocytopenia as a predictor of mortality in patients with ICU-acquired pneumonia. Journal of Clinical Medicine. 2019;8(6):843. https://doi.org/10.3390/jcm8060843
DOI
|
26 |
Julie R, Gooley TA, Richard A, Michael J. Hypocalcemia: a pervasive metabolic abnormality in the critically ill. American Journal of Kidney Diseases. 2001;37(4):689-698. https://doi.org/10.1016/S0272-6386(01)80116-5
DOI
|
27 |
Muller B, Becker KL, Kranzlin M, Schachinger H, Huber PR, Nylen ES, et al. Disordered calcium homeostasis of sepsis: association with calcitonin precursors. European Journal of Clinical Investigation. 2000;30(9):823-831. https://doi.org/10.1046/j.1365-2362.2000.00714.x
DOI
|
28 |
Moman RN, Gupta N, Sheikh NS, Varacallo M. Physiology, albumin[Internet]. treasure island(FL): statpearls; 2020[cited 2020 Jun 5]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459198/
|
29 |
Kendall H, Abreu E, Cheng AL. Serum albumin trend Is a predictor of mortality in ICU aatients with sepsis. Biological Research For Nursing. 2019;21(3):237-44. https://doi.org/10.1177/1099800419827600
DOI
|
30 |
Kang HR, Lee SN, Cho YJ, Jeon JS, Noh H, Han DC, et al. A decrease in serum creatinine after ICU admission is associated with increased mortality. PLoS One. 2017; 12(8):e0183156. https://doi.org/10.1371/journal.pone.0183156
DOI
|